ANPCY
Price:
$0.154
Market Cap:
$3.68M
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and C...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-04-28
Stock Exchange
OTC
Ticker
ANPCY
According to CelLBxHealth plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.24. This represents a change of -87.36% compared to the average of -1.90 of the last 4 quarters.
The mean historical PE Ratio of CelLBxHealth plc over the last ten years is -7.47. The current -0.24 PE Ratio has changed 221.27% with respect to the historical average. Over the past ten years (40 quarters), ANPCY's PE Ratio was at its highest in in the October 2019 quarter at 0. The PE Ratio was at its lowest in in the September 2021 quarter at -21.50.
Average
-7.47
Median
-6.65
Minimum
-17.81
Maximum
-1.52
Discovering the peaks and valleys of CelLBxHealth plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.59%
Maximum Annual PE Ratio = -1.52
Minimum Annual Increase = -73.49%
Minimum Annual PE Ratio = -17.81
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.13 | 39.81% |
| 2023 | -1.52 | -73.49% |
| 2022 | -5.73 | -67.82% |
| 2021 | -17.81 | 143.59% |
| 2020 | -7.31 | -19.24% |
| 2019 | -9.06 | -21.77% |
| 2019 | -11.57 | 93.12% |
| 2018 | -5.99 | 10.82% |
| 2017 | -5.41 | -33.78% |
| 2016 | -8.17 | -34.33% |
The current PE Ratio of CelLBxHealth plc (ANPCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.13
5-year avg
-6.90
10-year avg
-7.47
CelLBxHealth plc’s PE Ratio is less than OpGen, Inc. (13.69), less than Oxford BioDynamics Plc (-0.18), less than First Physicians Capital Group, Inc. (1.34), greater than TrivarX Limited (-13.49), less than Leveljump Healthcare Corp. (0.37), greater than Eco-Growth Strategies Inc. (-14.83), greater than Proteome Sciences plc (-1.99), less than Eagle Pharmaceuticals, Inc. (0.25), greater than Algorae Pharmaceuticals Limited (-11.55), greater than Red Light Holland Corp. (-2.82),
| Company | PE Ratio | Market cap |
|---|---|---|
| 13.69 | $93.66M | |
| -0.18 | $8.95M | |
| 1.34 | $10.07M | |
| -13.49 | $9.79M | |
| 0.37 | $1.04M | |
| -14.83 | $17.75M | |
| -1.99 | $8.86M | |
| 0.25 | $9.09M | |
| -11.55 | $8.27M | |
| -2.82 | $7.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CelLBxHealth plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CelLBxHealth plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CelLBxHealth plc's PE Ratio?
How is the PE Ratio calculated for CelLBxHealth plc (ANPCY)?
What is the highest PE Ratio for CelLBxHealth plc (ANPCY)?
What is the 3-year average PE Ratio for CelLBxHealth plc (ANPCY)?
What is the 5-year average PE Ratio for CelLBxHealth plc (ANPCY)?
How does the current PE Ratio for CelLBxHealth plc (ANPCY) compare to its historical average?